Stalking: Not Just for Movie Stars
Psychiatry General Medicine
Subscription Required
Being stalked is a serious psychological stressor that affects more women than men. Knowing the prevalence of stalking would be useful to determine whether questions . . .
By Nada L. Stotland, MD, MPH
November 2, 2005
Update on Cholinesterase Inhibitors for Alzheimer Disease
Psychiatry General Medicine
Subscription Required
Cholinesterase inhibitors are used commonly to treat Alzheimer disease (AD), but the magnitude of benefit has been controversial. In this systematic review, investigators analyzed 22 . . .
By Keith I. Marton, MD
October 19, 2005
Can "Unscientific" Therapies Be Studied Scientifically?
Psychiatry General Medicine
Subscription Required
Frontier therapies, defined as treatments “for which there is no plausible biomedical explanation,” and noetic therapies, which involve no tangible drugs or devices, are common, . . .
By Bruce Soloway, MD
October 19, 2005
Depressed Dads Affect Kids' Behavior
Psychiatry General Medicine
Subscription Required
Maternal depression after giving birth can affect children’s behavioral and emotional development, but does the same hold true for paternal depression in the postnatal period? . . .
By Sandra Ann Carson, MD
October 5, 2005
Androgen Levels Associated with Sexual Function?
Psychiatry General Medicine
Subscription Required
Although testosterone is often administered to treat sexual dysfunction in women, evidence of an association between low serum testosterone levels and low sexual function is . . .
By Sandra Ann Carson, MD
October 5, 2005
Modafinil for Shift-Work Sleep Disorder
Psychiatry General Medicine
Subscription Required
Modafinil (Provigil) was approved initially by the FDA to improve wakefulness in patients with narcolepsy. Last year, two new indications were added — obstructive sleep . . .
By Allan S. Brett, MD
October 5, 2005
Are Opioids Effective for Neuropathic Pain?
Psychiatry General Medicine
Subscription Required
These researchers reviewed published randomized studies of controlled trials of opioid monotherapy for neuropathic pain (primarily diabetic neuropathy, postherpetic neuralgia, and post-traumatic neuralgia), graded using . . .
By Edgar Ross, MD
October 5, 2005
Qualitative Neuropsychological Measures Help Distinguish FTD from AD
Psychiatry General Medicine
Subscription Required
Anticipating the development of potent but potentially toxic treatments for Alzheimer disease (AD), experts are directing much attention toward improving diagnostic accuracy. Diagnostic aids can . . .
By Michael D. Greicius, MD, MPH
October 5, 2005
Do Obesity Camps Work?
Psychiatry General Medicine
Subscription Required
The obesity epidemic has spawned a new summer activity — obesity camp. But, do such camps work? To find out, investigators in the U.K. compared . . .
By Howard Bauchner, MD
September 21, 2005
Alzheimer Disease: Sex Matters
Psychiatry General Medicine
Subscription Required
Many confounding variables have made it difficult to determine definitively whether risk for, and pathologic findings in, Alzheimer disease (AD) differ between women and men. . . .
By Nada L. Stotland, MD, MPH
September 21, 2005
